News &amp; Updates

A single phone consultation performs as well as traditional face-to-face consultations in terms of helping individuals with type 2 diabetes (T2D) achieve short-term glycaemic control, as shown in a study from Singapore.

One-time phone consultation compares favourably to in-person care for T2D management

18 May 2023

Lack of sleep reduces insulin sensitivity, fat oxidation in postmenopausal women

Sleep restriction for four nights results in decreased insulin sensitivity and fat oxidation among postmenopausal women, a study has shown.

Lack of sleep reduces insulin sensitivity, fat oxidation in postmenopausal women

Nirsevimab safe, effective against RSV lower respiratory tract infection

A single dose of nirsevimab administered before or during the respiratory syncytial virus (RSV) season provides protection against RSV lower respiratory tract infection (LRTI) hospitalization and very severe infection in infants, according to the preliminary results of a clinical trial conducted in real-world settings.

Nirsevimab safe, effective against RSV lower respiratory tract infection

Delayed capsulotomy much preferable over early procedure to prevent AEs

Ocular hypertension (OHT) and macular edema (ME) are the most common and relevant adverse events (AEs) following neodymium:yttrium-aluminum-garnet posterior capsulotomy (Nd:YAG-caps), reports a study. These AEs normally occur within 3 months after the procedure, which stresses the need for a close follow-up during this period or a delayed capsulotomy.

Delayed capsulotomy much preferable over early procedure to prevent AEs

Conventional vs shorter ocrelizumab infusions: which way to go?

In the ENSEMBLE PLUS study, there appears to be no difference in terms of the frequency and severity of infusion-related reactions (IRRs) between the conventional and shorter infusions of ocrelizumab for the treatment of early relapsing-remitting multiple sclerosis (RRMS). However, patients gravitated towards the shorter regimen more than the conventional method.

Conventional vs shorter ocrelizumab infusions: which way to go?

18 May 2023

SGLT2 inhibitors reduce HCC risk in T2DM patients with CHB

The use of sodium-glucose cotransporter 2 (SGLT2) inhibitors is associated with a reduced risk of incident hepatocellular carcinoma (HCC) in patients with coexisting type 2 diabetes mellitus (T2DM) and chronic hepatitis B (CHB), a territory-wide cohort study in Hong Kong has shown.

SGLT2 inhibitors reduce HCC risk in T2DM patients with CHB

18 May 2023

Surgery for drug-resistant epilepsy may improve quality of life

Undergoing epilepsy surgery appears to yield clinically meaningful gains in quality of life (QoL), according to the results of a meta-analysis.

Surgery for drug-resistant epilepsy may improve quality of life

18 May 2023

Too high, too low potassium levels bad for older patients with advanced CKD

High and low levels of serum potassium appear to contribute to an increase in the risk of death or kidney failure requiring replacement therapy (KRT) among older patients with chronic kidney disease (CKD) stage 4‒5, according to a study.

Too high, too low potassium levels bad for older patients with advanced CKD

CBD yields comparable benefits in kids, adults with Lennox-Gastaut and Dravet syndrome

17 May 2023 by

Children with Lennox-Gastaut syndrome (LGS) and Dravet's syndrome (DS) achieve improvements in both seizure management and nonseizure outcomes following treatment with cannabidiol (CBD)—a success echoed in their adult counterparts, as shown in a study presented at AAN 2023.

CBD yields comparable benefits in kids, adults with Lennox-Gastaut and Dravet syndrome

Large for gestational age tied to higher cardiometabolic risks